Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline

被引:15
作者
Julian, Maria Teresa [1 ,2 ]
Alonso, Nuria [1 ,2 ,3 ,5 ]
Lupon, Josep [1 ,4 ,5 ,6 ]
Gavidia-Bovadilla, Giovana [7 ,8 ]
Ferrer, Elena [4 ]
de Antonio, Marta [1 ,4 ]
Lopez-Ayerbe, Jorge [4 ]
Domingo, Mar [1 ]
Santiago-Vacas, Evelyn [1 ]
Zamora, Elisabet [1 ,4 ,5 ,6 ]
Codina, Pau [1 ,4 ]
Moliner, Pedro [1 ,4 ]
Nunez, Julio [7 ,8 ,9 ]
Santesmases, Javier [1 ,5 ]
Puig-Domingo, Manel [2 ,5 ]
Bayes-Genis, Antoni [1 ,4 ,5 ,6 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Barcelona, Spain
[2] Hosp Badalona Germans Trias & Pujol, Endocrinol Dept, Barcelona, Spain
[3] Inst Salud Carlos III, Ctr Biomed Res Diabet & Associated Metab Dis CIBE, Madrid, Spain
[4] Hosp Badalona Germans Trias & Pujol, Cardiol Dept, Barcelona, Spain
[5] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[6] Inst Salud Carlos III, CIBER Cardiovasc, Madrid, Spain
[7] Eurecat, Technol Ctr Catalonia, Dept E Hlth, Barcelona, Spain
[8] INCLIVA, Hosp Clin Univ, Cardiol Dept, Valencia, Spain
[9] Univ Valencia, Dept Med, Valencia, Spain
关键词
Heart failure; Diabetes mellitus; Ejection fraction; Etiology; Long-term; Follow-up; VENTRICULAR EJECTION FRACTION; CARDIOVASCULAR OUTCOMES; MELLITUS; IMPACT; MORTALITY; EPIDEMIOLOGY; PROGNOSIS; DISEASE;
D O I
10.1186/s12933-020-01011-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Left ventricular ejection fraction (LVEF) trajectories and functional recovery with current heart failure (HF) management is increasingly recognized. Type 2 diabetes mellitus (T2D) leads to a worse prognosis in HF patients. However, it is unknown whether T2D interferes with LVEF trajectories. The aim of this study was to prospectively assess very long-term (up to 15 years) LVEF trajectories in patients with and without T2D and underlying HF. Methods Ambulatory patients admitted to a multidisciplinary HF clinic were prospectively evaluated by scheduled two-dimensional echocardiography at baseline, 1 year, and then every 2 years afterwards, up to 15 years. Statistical analyses of LVEF change with time were performed using the linear mixed effects (LME) models, and locally weighted error sum of squares (Loess) curves were plotted. Results Of the 1921 patients, 461 diabetic and 699 non-diabetic patients with LVEF < 50% were included in the study. The mean number of echocardiography measurements performed in diabetic patients was 3.3 +/- 1.6. Early LVEF recovery was similar in diabetic and non-diabetic patients, but Loess curves showed a more pronounced inverted U shape in diabetics with a more pronounced decline after 9 years. LME analysis showed a statistical interaction between T2D and LVEF trajectory over time (p = 0.009), which was statistically significant in patients with ischemic etiologies (p < 0.001). Other variables that showed an interaction between LVEF trajectories and T2D were male sex (p = 0.04) and HF duration (p = 0.008). Conclusions LVEF trajectories in T2D patients with depressed systolic function showed a pronounced inverted U shape with a marked decline after 9 years. Diabetic cardiomyopathy may underlie the functional decline observed.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis
    Dauriz, Marco
    Mantovani, Alessandro
    Bonapace, Stefano
    Verlato, Giuseppe
    Zoppini, Giacomo
    Bonora, Enzo
    Targher, Giovanni
    DIABETES CARE, 2017, 40 (11) : 1597 - 1605
  • [32] Identification of Silent Myocardial Ischemia in Patients with Long-Term Type 1 and Type 2 Diabetes
    Rokicka, Dominika
    Bozek, Anna
    Wrobel, Marta
    Nowowiejska-Wiewiora, Alicja
    Szymborska-Kajanek, Aleksandra
    Stoltny, Tomasz
    Gasior, Mariusz
    Strojek, Krzysztof
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (03)
  • [33] Frequency of Diabetic Cardiomyopathy Among Type-2 Diabetics Presenting as Heart Failure
    Muhammad, Zil
    Hashmi, Asif
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2013, 23 (08): : 538 - 542
  • [34] Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy
    Fantoni, Cecilia
    Regoli, Francois
    Ghanem, Ali
    Raffa, Santi
    Klersy, Catherine
    Sorgente, Antonio
    Faletra, Francesco
    Baravelli, Massimo
    Inglese, Luigi
    Salerno-Uriarte, Jorge A.
    Klein, Helmut U.
    Moccetti, Tiziano
    Auricchio, Angelo
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (03) : 298 - 307
  • [35] Short- and Long-term Prognosis of Patients With Acute Heart Failure With and Without Diabetes: Changes Over the Last Three Decades
    van den Berge, Jan C.
    Constantinescu, Alina A.
    Boiten, Hendrik J.
    van Domburg, Ron T.
    Deckers, Jaap W.
    Akkerhuis, K. Martijn
    DIABETES CARE, 2018, 41 (01) : 143 - 149
  • [36] Long-term survival of a cohort of patients with heart failure: Perspective from the real world
    Mourino Lopez, V. M.
    Cid Conde, L.
    Alves Perez, M. T.
    Lopez Castro, J.
    EUROPEAN GERIATRIC MEDICINE, 2017, 8 (04) : 304 - 309
  • [37] Prognostic value of long-term blood pressure changes in patients with chronic heart failure
    Schmid, Florian A.
    Schlager, Oliver
    Keller, Philipp
    Seifert, Burkhardt
    Huang, Ruizhu
    Frohlich, Georg M.
    Luscher, Thomas F.
    Ruschitzka, Frank
    Enseleit, Frank
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (07) : 837 - 842
  • [38] Monocytes may be favorable biomarker and predictor of long-term outcome in patients with chronic heart failure A cohort study
    Charach, Gideon
    Rogowski, Ori
    Kamiel, Eli
    Charach, Lior
    Grosskopf, Itamar
    Novikov, Ilya
    MEDICINE, 2019, 98 (38)
  • [39] Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
    Gu, Jun
    Pan, Jian-an
    Fan, Yu-qi
    Zhang, Hui-li
    Zhang, Jun-feng
    Wang, Chang-qian
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [40] Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure
    Kosiborod, Mikhail
    Gause-Nilsson, Ingrid
    Xu, John
    Sonesson, Christian
    Johnsson, Eva
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1215 - 1221